Hi E, Join us at the Fierce Biotech Summit in Boston, MA on September 19-20, 2022 to hear how pharma and biotech leaders approach R&D decision-making. You’ll have a chance to learn how companies define value and what drives their motivations as well as steps organizations can take to mitigate risks and chart out a path that will ensure success. Take a look at some of the confirmed speakers including: - Andrew Allen, CEO, Gritstone Bio
- Fabrice Chouraqui, CEO, Cellarity
- Giuseppe Ciaramella, President and Chief Scientific Officer, Beam Therapeutics
- Kimberly Doggett, Head of Clinical Trial Diversity and Program Delivery Leads, UCB
- John Evans, Chief Executive Officer and Board Member, Beam Therapeutics
- Molly Gibson, Ph.D, Co-founder, Chief Strategy and Chief Innovation Officer, Generate Biomedicines
- Andrew A. Radin, Co-founder and CEO, Aria Pharmaceuticals
- Thomas Schuetz, CEO, Compass Therapeutics
Rachel Zolot Schwartz, MBA, VP, Head of Business Development and Commercial, Volastra Therapeutics
|
